,outcome,arm 1,arm 2
0,intervention,zoledronic acid,placebo
0,percentage of patients with at least one SRE ( excluding HCM ),29.8 %,49.6 %
0,"percentage of patients with at least one SRE ( excluding HCM ), total study group",20 %,20 %
